Melrose Industries PLC (MLSPF)

Theseus Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	124	88	58	355	473	311
Cash & Short-Term Investments	124	88	58	355	473	311
Cash Growth	-34.39%	51.72%	-83.66%	-24.95%	52.09%	-39.26%
Accounts Receivable	393	661	620	1,104	944	1,346
Other Receivables	655	260	168	315	211	281
Receivables	1,048	921	788	1,419	1,155	1,627
Inventory	585	528	513	1,025	893	1,126
Prepaid Expenses	-	33	33	36	40	54
Other Current Assets	42	10	31	38	23	47
Total Current Assets	1,799	1,580	1,423	2,873	2,584	3,165
Property, Plant & Equipment	825	821	777	2,599	2,528	3,133
Long-Term Investments	66	77	121	497	516	464
Goodwill	-	970	961	2,585	2,850	3,640
Other Intangible Assets	2,782	1,911	2,149	3,943	4,213	5,178
Long-Term Accounts Receivable	-	1,193	838	647	491	426
Long-Term Deferred Tax Assets	612	651	527	373	250	180
Long-Term Deferred Charges	-	213	241	318	327	380
Other Long-Term Assets	1,246	20	67	152	263	114
Total Assets	7,330	7,436	7,104	13,987	14,022	16,680
Accounts Payable	1,505	580	501	1,257	1,016	1,153
Accrued Expenses	22	266	239	352	323	462
Short-Term Debt	53	8	54	63	5	151
Current Portion of Long-Term Debt	-	-	-	3	457	16
Current Portion of Leases	33	33	40	60	57	81
Current Income Taxes Payable	11	20	20	141	142	188
Current Unearned Revenue	-	522	367	18	22	20
Other Current Liabilities	87	322	419	1,084	1,102	1,292
Total Current Liabilities	1,711	1,751	1,640	2,978	3,124	3,363
Long-Term Debt	1,475	1,401	576	1,433	910	3,091
Long-Term Leases	236	204	152	306	319	474
Long-Term Unearned Revenue	-	336	316	26	22	14
Long-Term Deferred Tax Liabilities	528	517	482	619	614	732
Other Long-Term Liabilities	476	324	272	876	848	1,058
Total Liabilities	4,478	4,592	3,537	6,819	6,482	9,570
Common Stock	1	1	309	309	333	333
Additional Paid-In Capital	1,000	1,000	3,271	3,271	3,271	8,138
Retained Earnings	3,958	3,778	1,182	4,379	5,319	861
Comprehensive Income & Other	-2,107	-1,935	-1,195	-830	-1,416	-2,251
Total Common Equity	2,852	2,844	3,567	7,129	7,507	7,081
Minority Interest	-	-	-	39	33	29
Shareholders' Equity	2,852	2,844	3,567	7,168	7,540	7,110
Total Liabilities & Equity	7,330	7,436	7,104	13,987	14,022	16,680
Total Debt	1,797	1,646	822	1,865	1,748	3,813
Net Cash (Debt)	-1,673	-1,558	-764	-1,510	-1,275	-3,502
Net Cash Per Share	-1.29	-1.18	-0.54	-1.07	-0.81	-2.40
Filing Date Shares Outstanding	1,279	1,286	1,333	1,351	1,457	1,457
Total Common Shares Outstanding	1,279	1,286	1,333	1,351	1,457	1,457
Working Capital	88	-171	-217	-105	-540	-198
Book Value Per Share	2.23	2.21	2.68	5.27	5.15	4.86
Tangible Book Value	70	-37	457	601	444	-1,737
Tangible Book Value Per Share	0.05	-0.03	0.34	0.44	0.30	-1.19
Land	-	578	523	1,169	1,143	1,394
Machinery	-	1,036	1,027	3,128	2,722	2,995

Source: S&P Global Market Intelligence. Standard template. Financial Sources.